Smith & Nephew plc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Smith & Nephew plc trades at $27.21 (market cap $11.31B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $339.46M). The key difference: Smith & Nephew plc is far larger — about 33.3× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Smith & Nephew plc pays a 2.95% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 120 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| SNN | XDTE | |
|---|---|---|
Market Cap | $11.31B | $339.46M |
Volume | 1,050,005 | 214,614 |
Sector | Health | Income / Options Overlay |
52-Week High | $37.17 | $44.76 |
52-Week Low | $26.42 | $36.00 |
Typical Hold Time | 120 Days | 54 Days |
Enterprise Value | $14.35B | — |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $26.96, near its 52-week low, with a bearish technical signal. The company has shown improving fundamentals, with revenue growing from $5.2B in 2022 to $6.16B in 2025 and net income margin expanding to 10.08%. Recent product launches, like the EVOS PELVIC System, highlight innovation, but the stock faces negative sentiment from analyst downgrades and CFO departure news.
The outlook is mixed: strong profitability and cash flow support value, but bearish technicals and cautious analyst consensus (26% buy, 65% hold) suggest limited near-term upside. Key risks include execution challenges and competitive pressures. Investors should weigh solid fundamentals against weak market sentiment.
No Aura AI signal available yet.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →